ANDREA GUZMAN: Open Payments
NPI 1639843840 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$415 in 17 payments from 11 companies in 2025. Trend: 2023 $1,216 · 2024 $558 · 2025 $415
Food & beverage: $415
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 3 | $70 |
| Globus Medical, Inc. | 1 | $64 |
| Bausch Health US, LLC | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Lundbeck LLC | 1 | $30 |
| Alkermes, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
Products named: REXULTI, Azstarys, Senza, APLENZIN, FANAPT, CAPLYTA, ARISTADA, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
